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Abstract
Objective To assess the contribution of modifiable risk factors to social
inequalities in the incidence of type 2 diabetes when these factors are
measured at study baseline or repeatedly over follow-up and when long
term exposure is accounted for.
Design Prospective cohort study with risk factors (health behaviours
(smoking, alcohol consumption, diet, and physical activity), body mass
index, and biological risk markers (systolic blood pressure, triglycerides
and high density lipoprotein cholesterol)) measured four times and
diabetes status assessed seven times between 1991-93 and 2007-09.
Setting Civil service departments in London (Whitehall II study).
Participants 7237 adults without diabetes (mean age 49.4 years; 2196
women).
Main outcomemeasures Incidence of type 2 diabetes and contribution
of risk factors to its association with socioeconomic status.
Results Over a mean follow-up of 14.2 years, 818 incident cases of
diabetes were identified. Participants in the lowest occupational category
had a 1.86-fold (hazard ratio 1.86, 95% confidence interval 1.48 to 2.32)
greater risk of developing diabetes relative to those in the highest
occupational category. Health behaviours and bodymass index explained
33% (−1% to 78%) of this socioeconomic differential when risk factors
were assessed at study baseline (attenuation of hazard ratio from 1.86
to 1.51), 36% (22% to 66%) when they were assessed repeatedly over
the follow-up (attenuated hazard ratio 1.48), and 45% (28% to 75%)
when long term exposure over the follow-up was accounted for
(attenuated hazard ratio 1.41). With additional adjustment for biological
risk markers, a total of 53% (29% to 88%) of the socioeconomic
differential was explained (attenuated hazard ratio 1.35, 1.05 to 1.72).
Conclusions Modifiable risk factors such as health behaviours and
obesity, when measured repeatedly over time, explain almost half of the
social inequalities in incidence of type 2 diabetes. This is more than was
seen in previous studies based on single measurement of risk factors.
Introduction
Diabetes is a major cause of morbidity and premature mortality
worldwide.1 2 In 2011 theWorld Health Organization estimated
that as many as 346 million people lived with the disease, 90%
of whom had type 2 diabetes.3 In addition to its own treatment
burden, which exacts enormous healthcare expenditure,4 type
2 diabetes is also an established risk factor for cardiovascular
diseases,5 selected cancers,6 and possibly mood disorder and
dementia.7 Thus, identification of those groups at increased risk
of type 2 diabetes, together with an understanding of the
mechanisms involved, remains a public health priority. Research
has now established that the occurrence of type 2 diabetes is
not evenly distributed across society: in high income countries,
the lower socioeconomic groups are disproportionately
affected.8-12 However, much remains to be learnt about the
modifiable risk factors that contribute to socioeconomic
variations in type 2 diabetes.
Differences in the availability or affordability of healthy foods
or places to exercise, differential access to healthcare services
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and health information, and differences in health related
behaviours between socioeconomic groups have all been
proposed as potential explanations for the social patterning of
type 2 diabetes.13 14 Among these, physical inactivity, obesity,
unhealthy diet, and cigarette smoking are established risk factors
for the development of the disease and have been shown to be
more prevalent among the disadvantaged socioeconomic
groups.15-20 They are thus potentially important mediators of the
association between socioeconomic status and type 2 diabetes.
However, previous studies suggest that these factors can explain
only about a third of social inequalities in type 2 diabetes.10 12 21 22
In a recent study in the British Whitehall II cohort, we showed
that health behaviours explain a greater proportion of social
inequalities in mortality when they are assessed repeatedly over
the follow-up rather than at baseline only.23 Most studies on
type 2 diabetes offer only a one-off measurement of health
behaviours, so previous studies may have underestimated their
contribution. In this study, we used data from the Whitehall II
cohort to assess the contribution of smoking, alcohol
consumption, dietary behaviours, physical activity, and body
mass index to social inequalities in the incidence of type 2
diabetes. We compared their role when they were assessed at
study baseline or repeatedly over the follow-up and when long
term exposure was accounted for. Furthermore, we evaluated
the additional contribution of biological risk markers for type
2 diabetes that are commonly measured in clinical settings:
systolic blood pressure, triglycerides, and high density
lipoprotein cholesterol.
Methods
Study population and design
The Whitehall II study was established in 1985 among 10 308
(3413 women) London based civil servants aged 35-55 years.24
The first examination (phase 1) took place during 1985-88 and
involved a clinical examination and a self administered
questionnaire. A 75 g oral glucose tolerance test was done for
the first time at phase 3 (1991-93; n=8815) and repeated at phase
5 (1997-99), phase 7 (2003-04), and phase 9 (2007-09).
Therefore, the phase 3 examination is the baseline for the
analyses we report here. We included participants free of type
2 diabetes at phase 3 and followed them for incident diabetes
up to phase 9. Additional questionnaire only phases also assessed
diabetes status at phase 4 (1995-96), phase 6 (2001), and phase
8 (2006).
Socioeconomic status
Socioeconomic status was based on participants’ occupational
position at phase 3 and categorised into high (administrative),
intermediate (professional/executive), and low (clerical/support).
This measure is a comprehensive marker of socioeconomic
circumstances and is related to education, salary, social status,
and level of responsibility at work.24 25
Diabetes risk factors and risk markers
Health behaviours were assessed at phases 1, 3, 5, and 7. Current
smoking was self reported and classified as yes/no. Alcohol
consumption was assessed by using questions on the number
of alcoholic drinks consumed in the previous week, then
converted to number of alcohol units consumed per week and
categorised as “abstainers” (0 units/week), “moderate drinkers”
(1-21/1-14 units/week for men/women), or “heavy drinkers”
(≥21/≥14 units/week for men/women).26
Overall diet was assessed by calculating a score of adherence
to healthy dietary guidelines provided by the alternative healthy
eating index.27 28 This index was based on intake levels of
vegetables, fruit, nuts, and soy, white to red meat ratio, total
fibre, trans fat, polyunsaturated to saturated fatty acids ratio,
long term multivitamin use, and alcohol consumption.28 The
score was then trichotomised on the basis of tertiles. As the
alternative healthy eating index was not available for phase 1,
a diet score was calculated by using information on fruit and
vegetable intake and the type of bread andmilk most commonly
consumed, as described previously.23
Physical activity was assessed by using questions on the
frequency and duration of participation in moderate or vigorous
physical activity at phases 1 and 3. At phases 5 and 7, the
questionnaire included 20 items on frequency and duration of
participation in different physical activities that were used to
calculate hours per week at each intensity level.29 Participants
were classified as “active” (≥2.5 hours/week of moderate or ≥1
hour/week of vigorous physical activity), “inactive” (≤1
hour/week of moderate and ≤1 hour/week of vigorous physical
activity), or “moderately active” (if not active or inactive).
Height and weight were measured at phases 1, 3, 5, and 7 by
following standard procedures. Body mass index was then
calculated and categorised in three groups (normal, <25;
overweight, 25-29; obese, ≥30) on the basis of WHO
recommendation.30
Biological risk markers related to type 2 diabetes were drawn
from phases 1, 3, 5, and 7 and categorised into high and low
risk groups.31 32High triglycerides were defined as ≥1.7mmol/L
and low high density lipoprotein cholesterol as <1.0 mmol/L in
men and <1.2 mmol/L in women. High systolic blood pressure
was defined as ≥140 mm Hg. At phase 1, high density
lipoprotein cholesterol measurements were available for only
1208 participants and triglycerides for only 1758.We predicted
missing high density lipoprotein cholesterol data by using data
on apolipoprotein A I, as described previously.33 Cumulative
exposure to high triglycerides concentrations between phases
1 and 3 could not be assessed.
Ethnicity was drawn from phase 1 and categorised as
white/non-white. Family history of type 2 diabetes (parents and
siblings) was self reported at phases 1 and 2 and categorised as
yes/no.
Incident type 2 diabetes
Venous blood was taken after a requested minimum five hour
fast before participants had a standard 75 g two hour oral glucose
tolerance test at study phases 3, 5, 7, and 9. Glucose samples
were drawn into fluoride monovette tubes and centrifuged on
site within one hour. Blood glucose was measured by using the
glucose oxidase method, as previously described.34 At each
phase, diabetes was defined by WHO criteria based on fasting
glucose ≥7.0 mmol/L or two hour glucose ≥11.1 mmol/L.35
Participants reporting diabetes diagnosed by a doctor or use of
antidiabetic drugs were classified as having diabetes regardless
of their oral glucose tolerance test results. The date of diagnosis
of diabetes was assigned according to the interval method as
the midpoint between the first visit with a diagnosis of diabetes
and the last visit without diabetes.34
Statistical analysis
We applied multivariate imputation based on sex, age, ethnicity,
socioeconomic status, health behaviours, body mass index, and
biological markers at the preceding phase to impute missing
values on health behaviours, body mass index, or biological
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risk markers at phases 3, 5, and 7. Twenty per cent of the
participants had at least one value imputed at one of the
follow-ups.
As no differences related to sex or ethnicity were apparent in
the association between socioeconomic status and incidence of
type 2 diabetes (hazard ratio 1.85, 95% confidence interval 1.45
to 2.45, among men and 1.71, 1.16 to 2.43, among women, P
for interaction=0.80; 1.89, 1.49 to 2.41, among white people
and 1.59, 0.85 to 2.95, among non-white people, P for
interaction=0.98), we pooled data for the two sexes and the two
ethnic groups and adjusted analyses for sex and ethnicity. We
used Cox regression to examine the association of
socioeconomic status, health behaviours, body mass index, and
biological risk markers with incident diabetes. As tests did not
suggest departure from a linear trend (P for departure from a
linear trend=0.20), we used socioeconomic status as a continuous
three level variable. Sensitivity analysis using socioeconomic
status as a categorical variable yielded similar results
(supplementary table G).We squared the hazard ratio associated
with a unit change in socioeconomic status to yield the hazard
ratio for lowest versus highest category of socioeconomic status.
We firstly adjusted Cox regressionmodels for age, sex, ethnicity,
and family history of diabetes (model 1 or reference model 1).
We then entered health behaviours and body mass index first
individually and then simultaneously into model 1. Model 2
included adjustment for all health behaviours, and model 3 (or
reference model 2 for further model comparisons) included
adjustment for all health behaviours and body mass index.
Subsequently, we entered the biological markers individually
into model 3, and we finally entered all risk factors/markers
simultaneously into a full multivariable model (model 4).
We determined the contribution of each risk factor/marker in
explaining the association between socioeconomic status and
type 2 diabetes by calculating the percentage attenuation in the
β coefficient for socioeconomic status after inclusion of the risk
factor in question in the reference model: “100×(βref model−βref
model+risk factor(s))/(βrefmodel)”. We calculated a 95% confidence interval
around the percentage attenuation by using a bootstrap method
with 1000 re-samplings. We repeated the analyses for the role
of risk factors/markers in the association between socioeconomic
status and type 2 diabetes three times using different
assessments. Firstly, we entered risk factors/markers as assessed
at the baseline of the study (phase 3). Secondly, we assessed
them longitudinally over the follow-up (phases 3, 5, and 7) and
entered them in the Cox regressions as time dependent variables.
Thirdly, we extended this model to assess long term exposure
to the risk factors/markers. We assessed this by adjusting, at
each follow-up period, for the risk factors/markers at the current
phase plus at the previous phase (two phases capturing an
exposure period of approximately five years). Thus, for the
follow-up period between phases 3 and 5, we entered risk
factors/markers assessed at phase 3 into the model together with
the risk factors/markers assessed at phase 1. For the follow-up
period between phases 5 and 7, were entered risk factors/markers
collected at phases 3 and 5 simultaneously, and for the follow-up
period between phases 7 and 9, we entered risk factors/markers
from phases 5 and 7 together. We tested the proportional hazard
assumptions for Cox regression models by using Schoenfeld
residuals and found them not to be violated (all P values ≥0.05).
We used the statistical software Stata 11.1 and SAS 9.2
(%BOOT and %BOOTCI macros) for analyses.
Results
Of the 8815 participants who took part in the phase 3
examination (that is, the baseline of the analyses reported here),
we excluded 1578 for one or more of the following reasons:
prevalent type 2 diabetes at phase 3 (n=162), missing follow-up
on type 2 diabetes status (n=588), and missing data on risk
factors/markers at phase 1 (n=1392). The final sample consisted
of 7237 participants (2196 women). Excluded participants were
more likely to belong to the low socioeconomic status group
and were slightly older than those included in the analyses
(P<0.001).
Table 1⇓ shows baseline characteristics of the participants
included in the analysis. During the mean 14.2 years follow-up,
818 incident cases type 2 diabetes were identified on the basis
of a 75 g oral glucose tolerance test (n=425; 52%), use of
antidiabetic drugs (n=188; 23%), or diagnosis by a physician
(n=205; 25%). Participants in the lowest socioeconomic category
had an almost twofold higher incidence of type 2 diabetes than
those in the highest category (10.9 v 5.6 per 1000 person years).
The prevalences of smoking, unhealthy diet, physical inactivity,
obesity, high triglyceride concentration, and low high density
lipoprotein cholesterol were higher in the lowest compared with
the highest socioeconomic group (P<0.001), whereas heavy
drinking wasmore common in the highest socioeconomic group
(P<0.001). Socioeconomic status was unrelated to high blood
pressure (P=0.72).
Table 2⇓ shows results for the association between risk
factors/markers for diabetes and incidence of type 2 diabetes.
Unhealthy behaviours were related to an increased risk of
developing type 2 diabetes over the follow-up. As anticipated,
the associations of overweight (hazard ratio 1.92, 95%
confidence interval 1.64 to 2.25) and obesity (4.79, 3.96 to 5.80)
with incidence of type 2 diabetes were particularly strong.
Hypertension and adverse lipid categories were also associated
with type 2 diabetes, as was family history of diabetes.
Table 3⇓ shows results for the association between
socioeconomic status and incidence of type 2 diabetes, as well
as the contribution of health behaviours, body mass index, and
biological risk markers assessed at phase 3 to this association.
The hazard ratio for the lowest versus the highest socioeconomic
status was 1.86 (1.48 to 2.32). This was attenuated by 17%when
we controlled for health behaviours at baseline and by 18%
when we controlled for body mass index. Overall, health
behaviours and body mass index attenuated the association
between socioeconomic status and type 2 diabetes by 33% (−1%
to 78%). Adjustment for baseline biological risk markers
(entered as continuous variables in the model) lowered the
association by an additional 12%. In total, 45% (17% to 105%)
of the socioeconomic gradient in type 2 diabetes was explained.
In table 4⇓ shows the results when the risk factors/markers were
assessed repeatedly over the follow-up. The first column shows
that with longitudinal assessment over the follow-up, health
behaviours and bodymass index in combination explained 36%
(22% to 64%) of the association between socioeconomic status
and type 2 diabetes. This proportion increased to 45% (28% to
77%) when we additionally took blood lipids and systolic blood
pressure into account. The right side of table 4⇓ shows results
of simultaneous adjustment for long term exposure to the risk
factors/markers and their changes over time. In this model,
health behaviours attenuated the socioeconomic status
coefficient by 24% and bodymass index alone by 23%; the total
percentage attenuation due to health behaviours and body mass
index was 45% (28% to 75%). Blood lipids and blood pressure
contributed to an additional 8%, and in the final fully adjusted
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model 53% (29% to 88%) of the association between
socioeconomic status and type 2 diabetes was explained.
Sensitivity analyses
We repeated all analyses in subgroups including only
participants with complete data, only those who were free from
coronary heart disease at baseline, and only white participants,
as well as including adjustment for waist circumference and
body mass index assessed at age 25. These yielded similar
results to those reported in the main analysis (results available
on request).
We repeated all analyses for men and women separately
(supplementary tables A to D). Although results did not
materially differ between the sexes, modifiable risk factors
tended to explain a larger proportion of the socioeconomic
gradient in type 2 diabetes in women than in men (attenuation
for the model accounting for long term exposure to the risk
factors: 42% in men and 81% in women, P for difference
between the two estimations=0.43).
To examine whether our results are robust across different
indicators of socioeconomic status, we repeated all analyses
using education and income as alternative measures. Our
findings of a major contribution of modifiable risk factors to
socioeconomic differences in type 2 diabetes were consistent
across the indicators of socioeconomic status (supplementary
tables E and F).We also repeated the analysis using employment
grade in six categories (supplementary table G). Again, the
results were very similar to those in the main analysis based on
employment grade in three categories.
Finally, we used three standard approaches to examine whether
missing data on risk factors at baseline affected the findings.
Firstly, we repeated the analysis using only three of the risk
factors examined: smoking, alcohol consumption, and body
mass index. These risk factors were available on a larger sample
of the population (n=7750), allowing us to assess whether their
role in explaining socioeconomic differences in type 2 diabetes
in this larger sample was similar to that found in the smaller
sample included in the main analysis. Regarding the model with
baseline assessment of these risk factors, the contribution of
smoking was 10% in the larger sample compared with 9% in
the smaller sample. The contribution of alcohol consumption
was 3% versus 3%, and that of bodymass index was 20% versus
18%. Secondly, we used “inverse probability weighting” to
correct the estimates for non-response.36 These analyses yielded
similar results to those reported in the main analysis
(supplementary table H). Thirdly, we used multiple multivariate
imputation to replace missing values for risk factors at the study
baseline (Stata ice/micombine procedures). Analyses on the
imputed dataset (n=8232; 927 incident diabetes cases) yielded
results virtually identical to those reported in the main analysis
(results available on request).
Discussion
This study aimed to quantify the contribution of health
behaviours, bodymass index, and biological risk markers to the
association between socioeconomic status and the incidence of
type 2 diabetes in a population of British civil servants followed
up for a mean of 14.2 years. We found that health behaviours
and body mass index explained 33% of socioeconomic
differences in incidence of diabetes when they were assessed
at study baseline, 36% when assessed repeatedly over the
follow-up, and 45% when we additionally accounted for long
term exposure. In these three assessments, bodymass index was
the most important single contributing factor. After we
additionally took account of adverse lipid profile and systolic
blood pressure, up to 53% of the association between
socioeconomic status and type 2 diabetes was explained.
Strengths and weaknesses
This study has two major strengths. Firstly, it is to our
knowledge the first to assess the effect of health behaviours and
body mass index on socioeconomic differences in type 2
diabetes by using different assessments of current and long term
exposure to these factors over the follow-up. This allowed us
to examine the possibility that changes in these factors over the
study period or a long term exposure might have yielded
different results. Secondly, unlike previous studies, we provide
a confidence interval around the percentage attenuation of the
association between socioeconomic status and type 2 diabetes
after inclusion of the risk factors examined. Adding a degree of
precision to the estimates of the contribution of risk factors to
social inequalities greatly helps with the interpretation of these
findings.
This study also has some limitations. As the findings were from
an occupational cohort, they may not fully apply to the general
population, which also includes people not in paid employment.
Despite a high response to the survey at the successive data
collection phases, loss to follow-up accumulated over the
extended time period, as is inevitable in long term prospective
studies. We used an imputation procedure to replace missing
values for the risk factors considered. Our sensitivity analyses
showed that results from analyses using complete case data
differed little from those using imputed data.
Comparison with previous studies
In our study, participants in the lowest occupational group had
a 1.86-fold greater risk of developing type 2 diabetes over the
follow-up compared with those in the highest occupational
group. This is slightly higher than the 1.31-fold increased risk
of incident type 2 diabetes in the lowest category of
socioeconomic status found in the most recent meta-analysis of
cohort studies in high income countries.11 Health behaviours
and body mass index explained about a third of socioeconomic
differences in incidence of type 2 diabetes when assessed at
baseline—this is consistent with previous reports on this and
other cohorts10 21 22—but up to 45% when we accounted
simultaneously for changes over time and long term exposure.
The difference in contributions of risk factors when measured
once compared with repeatedly was mainly due to an increased
explanatory power of physical activity (from 1% to 10%) and
body mass index (from 18% to 23%). Long term exposure to
these risk factors may be captured better when it is assessed at
multiple points in time rather than on just one occasion.
Moreover, adjustment for the long term effect of body mass
index may be important, as duration of exposure to obesity has
been linked to increased risk of type 2 diabetes.37
Recent studies have suggested that social inequalities in type 2
diabetes might be larger in women than in men,38 39 whereas in
our study the socioeconomic gradient in incidence of type 2
diabetes did not differ by sex. Our data came from an
occupational cohort, which may result in the characteristics for
men and women being more homogeneous than in the general
population. Moreover, most studies reporting sex differences
in the social patterning of type 2 diabetes were based on
prevalence data,38 39 whereas our study examined incidence.
However, in our study the modifiable risk factors examined
tended to explain a larger proportion of the association between
socioeconomic status and type 2 diabetes in women than in men,
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because of sex differences in the social patterning of these risk
factors.
In contrast to our previously published paper on socioeconomic
differences in mortality,23 the contribution of health behaviours
to social inequalities in incidence of type 2 diabetes did not
increase substantially when we used repeated assessments of
the behaviours during the follow-up rather than using only one
assessment at baseline. The effect of changes in unhealthy
behaviours may be more pronounced on determinants of
mortality than for type 2 diabetes. Alternatively, reverse
causation could partly explain the larger proportion of
socioeconomic differences explained with repeated versus
baseline only assessment when the outcome is mortality instead
of morbidity.40 In mortality analyses, changes in unhealthy
behaviours may be elicited by non-fatal chronic diseases
preceding death.
Meaning and implications of study
Of the modifiable risk factors examined, body mass index
contributed the most and alone explained about 20% of
socioeconomic differences. The major role of excess weight in
the onset of type 2 diabetes is well established.41Asweight gain
is strongly socially patterned, the finding that obesity also plays
a major role in shaping social inequalities in type 2 diabetes is
not surprising. In contrast, with only 8% and 1% attenuation of
the association between socioeconomic status and type 2
diabetes (8% and 10% when we assessed long term exposure),
the effects of diet and physical activity were smaller than one
would expect given that these behaviours were also strongly
socially patterned. We might have underestimated their effect
relative to that of body mass index because this is measured
with greater precision than questionnaire based diet and physical
activity assessment.42 43
Although smoking was associated with incidence of type 2
diabetes and was strongly socially patterned, its contribution to
socioeconomic differences in type 2 diabetes was modest. The
role of alcohol consumptionwas also negligible. This is probably
because participants in the highest category of socioeconomic
status were more likely to be heavy drinkers than were those in
the lowest category, a finding also observed in other
occupational cohorts.44 We found that dyslipidaemia (high
triglycerides in particular) explained an additional 10% of
socioeconomic differences in incidence of type 2 diabetes. In
contrast, the contribution of hypertension was almost null,
consistent with equal distribution of elevated blood pressure
across socioeconomic groups and the lack of socioeconomic
inequalities in prescription of antihypertensive drugs in the
United Kingdom.45 The treatment of high triglycerides and low
high density lipoprotein cholesterol is not a primary aim in
clinical practice; these biomarkers are unlikely to affect the
social patterning of diabetes.46
The fact that unhealthy behaviours and body mass index
explained up to 45% of the socioeconomic gradient in type 2
diabetes in this population in early old age has important public
health implications. Type 2 diabetes can be delayed or prevented
among people at high risk who make intensive lifestyle
modifications.47 48 Further efforts should be made to promote
and enable the adoption of healthy lifestyles among the
disadvantaged fractions of society. Targeting diabetogenic lipid
profiles might additionally be considered,49 as in our study
dyslipidaemia (high triglycerides in particular) explained an
additional 10% of socioeconomic differences in incidence of
type 2 diabetes. However, the extent to which altered
concentrations of triglycerides are a consequence of increased
adiposity or insulin resistance or are an independent risk factor
for the development of type 2 diabetes remains unclear.50 51
Moreover, clinical implications should take into account the
fact that drugs that directly target triglycerides and high density
lipoprotein cholesterol are associated with a slight increase in
blood glucose concentrations, an unwanted side effect for people
at high risk of diabetes,52 and are less effective than expected.53
Unanswered questions
Similarly to previous findings on cardiovascular diseases in this
cohort,54 55 about 50% of the socioeconomic gradient in type 2
diabetes remained unexplained after we had accounted for all
major risk factors for the disease. Other potential mediators of
the association between socioeconomic status and type 2
diabetes in adults are psychosocial factors and psychological
states, such as chronic stressors and depression,13 56 exposure to
adverse socioeconomic circumstances in utero or during
childhood,57 or inadequate access to healthcare.13 However,
studies that have assessed the contribution of psychosocial
factors have found no evidence for an effect on social
inequalities in diabetes,10 21 andmedical care seems to contribute
more to social inequalities in management of diabetes than to
its onset.13Although evidence suggests that exposure to adverse
socioeconomic circumstances in early life or depression might
play a role in social inequalities in type 2 diabetes,56 58 to our
knowledge no study so far has investigated this question. Further
investigations based on longitudinally assessed risk factors are
therefore needed. Finally, as noted above, the extent to which
unhealthy diet and low physical activity would contribute to the
socioeconomic gradient in type 2 diabetes remains unknown
until these risk factors are assessed with greater precision at the
population level—for example, with objective measures.
Conclusions
Health behaviours and body mass index explain almost half of
the association between socioeconomic status and incidence of
type 2 diabetes. Adverse blood lipids, which might be an
intervention target for prevention of diabetes in the future, also
contributed to social inequalities associated with type 2 diabetes.
Given the increasing burden of type 2 diabetes and the observed
increase in social inequalities in prevalence of type 2 diabetes,52
further efforts to tackle these factors are urgently needed.
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Tables
Table 1| Study participants’ characteristics at phase 3 (baseline) and incidence of diabetes over 17.7 years of follow-up by socioeconomic
status. Values are numbers (percentages) unless stated otherwise
All (n=7237)P value*
Socioeconomic status
Low (n=1114; 15.4%)Intermediate (n=3292; 45.5%)High (n=2831; 39.1%)
818 (7.9)<0.001169 (10.9)407 (8.9)243 (5.6)Incidence of type 2 diabetes†
Demographics
49.4 (6.0)<0.00151.2 (6.0)48.8 (6.0)49.5 (5.8)Mean (SD) age (years)
5041 (69.7)<0.001298 (26.8)2273 (69.1)2470 (87.3)Men
6598 (91.2)<0.001833 (74.8)2971 (90.3)2794 (98.7)White ethnic group
786 (10.9)<0.001172 (15.4)368 (11.2)246 (8.7)Family history of type 2 diabetes
Health behaviours‡
960 (13.8)<0.001241 (22.4)485 (14.9)234 (7.4)Smoking
1135 (14.9)<0.00157 (9.8)505 (14.2)573 (18.7)Heavy drinking
2417 (33.6)<0.001396 (45.4)1212 (35.2)809 (24.9)Unhealthy diet
1430 (21.2)<0.001477 (30.3)612 (22.4)341 (14.4)Physical inactivity
Other metabolic risk factors‡
662 (9.5)<0.001176 (11.8)295 (9.8)191 (7.9)Obesity
1906 (26.3)<0.001284 (30.9)862 (26.9)760 (23.0)High triglycerides (≥1.7 mmol/L)
1350 (18.9)<0.001249 (24.0)629 (19.5)472 (15.1)LowHDL cholesterol (<1.0/1.2 mmol/L in men/women)
548 (7.7)0.7279 (7.9)252 (7.7)217 (7.5)High systolic blood pressure (≥140 mm Hg)
HDL=high density lipoprotein.
*For linear trend across socioeconomic categories.
†Age, sex, and ethnicity adjusted incidence rate per 1000 person years.
‡Age, sex, and ethnicity adjusted prevalence.
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Table 2| Association of health behaviours and other risk factors assessed at baseline (phase 3) with type 2 diabetes incidence (n=7237)
Hazard ratio* (95% CI)Behaviour/risk factor
2.15 (1.82 to 2.55)Family history of type 2 diabetes (yes v no)
1.47 (1.22 to 1.78)Smoking (yes v no)
Alcohol consumption:
1.21 (1.02 to 1.44)Abstainers (0 units/week) v moderate drinkers†
1.04 (0.85 to 1.27)Heavy (≥21/14 units/week for men/women) v moderate drinkers†
Diet:
1.36 (1.15 to 1.61)Unhealthy v healthy‡
0.96 (0.81 to 1.15)Moderately healthy v healthy‡
Physical activity:
1.33 (1.13 to 1.56)Inactive v active
1.25 (1.04 to 1.5)Moderately active v active
Body mass index:
1.92 (1.64 to 2.25)Overweight (25-29 v <25)
4.79 (3.96 to 5.80)Obese (≥30 v <25)
2.98 (2.59 to 3.42)High triglycerides§ (yes v no)
2.24 (1.93 to 2.59)Low high density lipoprotein cholesterol¶ (yes v no)
1.86 (1.51 to 2.28)High systolic blood pressure** (yes v no)
*Adjusted for age, sex, and ethnicity.
†1-21/1-14 units/week for men/women
‡Healthy=upper third of alternative healthy eating index (see Methods).
§≥1.7 mmol/L.
¶<1.0/1.2 mmol/L in men/women.
**≥140 mm Hg.
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Table 3| Contribution of baseline risk factors/markers (phase 3) in explaining social inequalities in type 2 diabetes incidence (n=7237)
% difference* (95% CI)Hazard ratio (95% CI)Baseline risk factors/markers
1.86 (1.48 to 2.32)Model 1†: lowest v highest socioeconomic status
−9 (−47 to 22)1.76 (1.40 to 2.21)Model 1 + smoking
−3 (−32 to 32)1.82 (1.45 to 2.29)Model 1 + alcohol
−8 (−44 to 22)1.76 (1.40 to 2.21)Model 1 + diet
−1 (−37 to 29)1.85 (1.47 to 2.32)Model 1 + physical activity
−17 (−58 to 15)1.67 (1.32 to 2.10)Model 2: model 1 + all health behaviours
−18 (−57 to 15)1.66 (1.32 to 2.08)Model 1 + body mass index
−33 (−78 to 1)1.51 (1.19 to 1.91)Model 3: model 2 (all health behaviours) + body mass index
−13‡ (−35 to 5)1.40 (1.11 to 1.77)Model 3 + triglycerides
−5‡ (−12 to 1)1.46 (1.16 to 1.85)Model 3 + high density lipoprotein cholesterol
−1‡ (−15 to 8)1.50 (1.19 to 1.91)Model 3 + systolic blood pressure
−45 (−105 to −17)1.40 (1.11 to 1.78)Model 4: all above risk factors
*Percentage attenuation in log HR=100×(βSES−βSES+risk factor(s))/(βSES), where β=log(HR).
†Adjusted for age, sex, ethnicity, and family history of type 2 diabetes.
‡Additional contribution of risk factor to model adjusted for all health behaviours and body mass index (model 3).
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Table 4| Contribution of repeatedly measured risk factors/markers in explaining social inequalities in type 2 diabetes incidence (n=7237)
Longitudinal + long term assessment†Longitudinal assessment*
Model % difference‡ (95% CI)Hazard ratio (95% CI)% difference‡ (95% CI)Hazard ratio (95% CI)
1.86 (1.48 to 2.32)1.86 (1.48 to 2.32)Model 1§: lowest v highest SES
−7 (−16 to −2)1.78 (1.42 to 2.23)−4 (−12 to 1)1.80 (1.44 to 2.26)Model 1 + smoking
−5 (−14 to 2)1.80 (1.43 to 2.26)−1 (−9 to 6)1.84 (1.47 to 2.32)Model 1 + alcohol
−8 (−16 to 3)1.76 (1.40 to 2.21)−8 (−15 to −3)1.77 (1.41 to 2.22)Model 1 + diet
−10 (−19 to −4)1.74 (1.39 to 2.19)−6 (−12 to −2)1.79 (1.43 to 2.24)Model 1 + physical activity
−24 (−43 to −11)1.60 (1.26 to 2.02)−15 (−29 to −5)1.69 (1.34 to 2.13)Model 2: model 1 + all health
behaviours
−23 (−41 to −13)1.61 (1.28 to 2.02)−22 (−39 to −13)1.62 (1.29 to 2.04)Model 1 + body mass index
−45 (−75 to −28)1.41 (1.11 to 1.78)−36 (−64 to −22)1.48 (1.17 to 1.88)Model 3: model 2 (all health
behaviours) + body mass index
−7¶ (−11 to 0)1.35 (1.06 to 1.71)−6¶ (−13 to 2)1.43 (1.13 to 1.81)Model 3 + triglycerides
−4¶ (−8 to 2)1.37 (1.07 to 1.75)−5¶ (−12 to 2)1.43 (1.13 to 1.81)Model 3 + HDL cholesterol
2¶ (−1 to 3)1.42 (1.12 to 1.8)1¶ (−1 to 2)1.49 (1.18 to 1.89)Model 3 + systolic blood
pressure
−53 (−88 to −29)1.35 (1.05 to 1.72)−45 (−77 to −28)1.41 (1.11 to 1.78)Model 4: all above risk factors
HDL=high density lipoprotein; SES=socioeconomic status.
*Adjustment for risk factors assessed at phases 3, 5, and 7.
†Risk factors updated at phases 3, 5, and 7 and additionally adjusted for risk factor at previous phase; cumulative exposure to high triglycerides not assessed for
time period between phases 1 and 3, owing to lack of data at phase 1.
‡Percentage attenuation in log HR=100×(βSES−βSES+risk factor(s))/(βSES), where β=log(HR).
§Adjusted for age, sex, ethnicity, and family history of type 2 diabetes
¶Additional contribution of risk factor to model adjusted for all health behaviours and body mass index (model 3).
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